Vanderbilt & Qsource Webinar Series

Size: px
Start display at page:

Download "Vanderbilt & Qsource Webinar Series"

Transcription

1 Vanderbilt & Qsource Webinar Series

2 Vanderbilt Medical Center Vanderbilt University Center for Quality Aging Qsource

3 Session #1: Introduction to Dementia Care & QAPI Session #2: Dementia & Behavioral Disturbances Session #3: Psychopharmacology in the Nursing Home Session #4: Principles of Non-pharmacologic Management & the Formulation of Behavioral Care Plans Session #5: The Implementation of Behavioral Strategies & the Management of Pharmacologic Interventions Session #6: Addressing Barriers to Change: the Perspective of Psychiatry, Nursing, and Medical Directors

4 Chat Monitor: Britt Kuertz, RDN Moderator: Emily Hollingsworth, MSW

5 How many people are in the room with you to view this webinar? (Please answer in the chat pane, and be sure to include your full facility name)

6 How would you describe your facility s current efforts to reduce antipsychotic medication use? A. We just recently started focusing on this topic and are trying to learn more. B. We ve been actively trying to reduce antipsychotic medications but have experienced challenges and need further guidance. C. We have successfully reduced antipsychotic medications but there is still room for more improvement.

7 Presenters: Beth Hercher, CPHQ, Qsource Carrie Plummer, PhD, ANP-BC, Vanderbilt School of Nursing James Powers, MD, Vanderbilt University Medical Center

8 James Powers, MD Carrie Plummer, PhD, ANP-BC Beth Hercher, CPHQ

9 1. To provide an overview of dementia and problem behaviors in nursing homes. 2. To describe the potential adverse effects of antipsychotic medications for managing problem behaviors. 3. To provide an introduction to QAPI and its application to reduce antipsychotic medications.

10 Of Medicare beneficiaries residing in Nursing Homes, 64% have Alzheimer s Disease (AD) or other dementias. 78% of nursing home residents with dementia exhibit behavioral and psychological symptoms of dementia (BPSD). 41% of residents with BPSD exhibit symptoms of psychosis.

11 Caring for a person with dementia requires an average of 197 more care hours per year than caring for someone without dementia. This number increases as the severity of cognitive impairment increases.

12 Wandering Sleep Disturbances Sexual Inappropriateness Verbal Agitation: Abnormal/Repetitive Vocalizations Physical Agitation: Repetitive Motor Activity Verbal and/ or Physical Aggression Crying Psychosis (delusions and/or hallucinations)

13 Centers for Medicare and Medicaid Services (CMS) Initiative released in April Office of Inspector General (OIG) reportoveruse of antipsychotics in nursing homes. Antipsychotic use factors into CMS- issued Star Rating.

14 CMS has developed a national partnership to improve the quality of care provided to individuals with dementia living in nursing homes This partnership is focused on delivering health care that is person-centered, comprehensive, and interdisciplinary. Reduce use of unnecessary antipsychotic medications

15 The average percentage of long-stay residents on antipsychotics: 18.7% in reporting nursing homes in the Unites States (CMS, 2015 Q1) 21.6% in Tennessee (CMS, 2015 Q1) CMS goal is to reduce antipsychotic use to 15% nationally (or 17% for Tennessee)

16 Associated Adverse Effects: Sedation Confusion/ Cognitive Worsening Worsening Psychotic Symptoms Restlessness/ Movement Disorders Slowness of Gait Increased Fall Risk Weight Gain Increased Blood Sugar

17

18 When antipsychotics are necessary how do we appropriately document this necessity? CMS guidelines: Must present a danger to the person with dementia or others, or cause the person with dementia to experience one of the following: Inconsolable or persistent distress, A significant decline in function, or Substantial difficulty receiving needed care.

19 How do we institute improvements at our facility?

20 The Model for Improvement What are we trying to accomplish? Aim How will we know that a change is an improvement? Measure What changes can we make that will result in improvement? Change

21 Specific Measurable Attainable Relevant Time-bound Example Aim: To reduce the percentage of residents receiving routine antipsychotics to manage problem behaviors by 10% in the next six months.

22 Determine which data to monitor routinely Set targets for performance in the areas you are monitoring Identify benchmarks for performance Develop a data collection plan, including: who will collect which data? who will review it? how frequently will it be collected and reported? Download resource at

23 Provide a Baseline Identify areas needing further investigations Identify areas needing improvement Evaluate impact of new changes or programs Effectiveness of quality improvement program Balancing measures (unexpected changes of program) Determine which changes resulted in improvements

24 How do you know the changes will produce the desired outcomes? Root Cause Analysis (RCA) Plan, do, study, act (PDSA) cycles

25 Helps identify the primary cause(s) of a problem to determine what happened determine why it happened determine what to do to reduce the likelihood of it happening again Tools: RCA Five Whys Worksheet Fishbone Diagram

26 Identify event to be investigated and what questions to ask Establish leadership team to review Describe what happened Identified the contributing factors Identify root causes Certification/QAPI/downloads/qapifiveelements.pdf

27

28 What are we trying to accomplish? In the next six months, our facility will reduce the number of residents with dementia who are receiving routine antipsychotics to manage problem behaviors. Think SMART: S Specific M Measurable A Attainable R Relevant T Time-bound

29 How will we know that a change is an improvement? We will track the incidence of antipsychotic use among high-risk residents by conducting weekly behavioral assessments

30 What changes can we make that will lead to improvement? We will document and implement nonpharmacological interventions for residents with behavioral disturbance

31 Monitor and modify effectiveness Changes that result in improvement Learning Hunches, theories, ideas e.g., action plans or interventions

32 QAPI is a new regulatory requirement facilities must adopt to avoid penalties A. True B. False

33 Full video available on project website:

34 Retired army colonel with dementia Hospitalized with UTI Structured geriatric ward Family meeting on goals of care

35

36 Medications for agitation should be a last resort after failing non-pharmacologic management Low-dose medications with continued efforts to reduce and eliminate psychotropics Avoid p.r.n. s

37

38 Patient-centered goals of care should be developed with the resident and family Medications for agitation should be a last resort Non-pharmacologic management techniques include Normalize day and night schedules Re-orient, re-direct Anticipate resident needs

39 Antipsychotic medication should be used only after non-pharmacological treatment has been attempted. A. True B. False

40 Antipsychotic medications are commonly used to manage problem behaviors (21.6% in TN) There are numerous potential adverse effects of these medications (e.g., sedation, confusion, falls) The QAPI framework can be used to safely and appropriately reduce the use of these medications There will be a second presentation of Session #1 on Tuesday, October 27 th at 1pm CST/ 2pm EST

41 Two options for attending Session 2: November 3rd (Tuesday) 1pm CST/ 2pm EST November 18th (Wednesday) 10am CST/ 11am EST

42 Emily Hollingsworth Britt Kuertz Project Website: Vanderbilt Center for Quality Aging for other resources

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Problem: For dementia patients, antipsychotic medications are prescribed

More information

9/11/2012. Clare I. Hays, MD, CMD

9/11/2012. Clare I. Hays, MD, CMD Clare I. Hays, MD, CMD Review regulatory background for current CMS emphasis on antipsychotics Understand the risks and (limited) benefits of antipsychotic medications Review non-pharmacologic management

More information

Psychotropic Medication. Including Role of Gradual Dose Reductions

Psychotropic Medication. Including Role of Gradual Dose Reductions Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which

More information

Reducing Antipsychotic Drug Use in Long Term Care

Reducing Antipsychotic Drug Use in Long Term Care Reducing Antipsychotic Drug Use in Long Term Care Janice S. Ceriotti, RPh, CGP Director of Clinical Services Omnicare Pharmacies / Eastern MO Goals and Objectives Understand the history of Antipsychotics

More information

How to use the CMS Hand in Hand Training for Dementia Care

How to use the CMS Hand in Hand Training for Dementia Care How to use the CMS Hand in Hand Training for Dementia Care How to use the CMS Hand in Hand Training for Dementia Care The purpose of Hand in Hand is to provide nursing homes with a high-quality staff training

More information

Integrating INTERACT into Interim Pharmacist Reviews

Integrating INTERACT into Interim Pharmacist Reviews Integrating INTERACT into Interim Pharmacist Reviews Chad R. Worz, Pharm.D. President, Medication Managers, LLC Adjunct Assistant Professor of Pharmacy Practice, University of Cincinnati, College of Pharmacy

More information

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal Management of Behavioral Symptoms in Dementia Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal Behavioral Symptoms Common & troubling At least one will occur in 61-92% of those with any dementia

More information

OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia

OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia Amy J. Osborn, NHA, PMP Executive Director, Health Services Advisory Group (HSAG) Rick Foley, PharmD,

More information

Re: Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities

Re: Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities Public Policy Division 202.393.7737 p 1212 New York Ave NW 866.865.0270 f Suite 800 www.alz.org Washington, DC 20005 Andy Slavitt Acting Administrator Centers for Medicare & Medicaid Services Department

More information

12/17/2012. Unnecessary Drugs

12/17/2012. Unnecessary Drugs Nursing Home Social Work Webinar Series December 19, 2012 Dr. Robin P. Bonifas, PhD, MSW Arizona State University School of Social Work Importance of familiarity with psychotropic medication regulations.

More information

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia

More information

New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm. Presenters.

New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm. Presenters. New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm Call-In Information: 1-888-895-6448 Code: 7362894 Log-In Information: https://qualidigm.adobeconnect.com/affinity/

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

Behavioural and Psychological Symptoms and Medications Presentation

Behavioural and Psychological Symptoms and Medications Presentation 1 2 Vover s research indicated that antipsychotic med are frequently used for individual presenting with disruptive behaviours. This often combined with physical restraints Efficacy of use not justify

More information

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Stephen Eide R. Ph Oni Kinberg LCSW, MSSW Updates to the SOM On March 25, 2016 CMS sent out updates

More information

Risks of Antipsychotics use In Dementia

Risks of Antipsychotics use In Dementia AHCA/NCAL Quality Initiative for Assisted Living Webinar Series: Safely Reducing the Off-Label Use of Antipsychotics Risks of Antipsychotics use In Dementia Sanjay P. Singh, MD Chairman & Professor, Department

More information

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Measure Description Percentage of patients with dementia for whom there was a documented screening* for behavioral

More information

Vanderbilt & atom Alliance Webinar Series

Vanderbilt & atom Alliance Webinar Series Vanderbilt & atom Alliance Webinar Series Vanderbilt University Medical Center Vanderbilt University Center for Quality Aging atom Alliance Session #2: Dementia & Behavioral Disturbances Session #3: Psychopharmacology

More information

Drugs used to relieve behavioural and psychological symptoms in dementia

Drugs used to relieve behavioural and psychological symptoms in dementia alzheimers.org.uk Drugs used to relieve behavioural and psychological symptoms in dementia People with dementia may develop behavioural and psychological symptoms including restlessness, aggression, delusions,

More information

Antipsychotic Medications

Antipsychotic Medications TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood

More information

Behavior Problems: in Long Term Care and Assisted Living

Behavior Problems: in Long Term Care and Assisted Living Behavior Problems: Dementia and Mental Illness in Long Term Care and Assisted Living Module I Dr. David A. Smith, M.D., FAAFP, CMD mmlearn.org is a program of Morningside Ministries Cell Phones and Pagers

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP Dementia and Fall Geriatric Interprofessional Training Wael Hamade, MD, FAAFP Prevalence of Dementia Age range 65-74 5% % affected 75-84 15-25% 85 and older 36-50% 5.4 Million American have AD Dementia

More information

QAPI Relay Residents Who Self-Report Moderate to Severe Pain Long-Stay Quality Measure Coding Improvements

QAPI Relay Residents Who Self-Report Moderate to Severe Pain Long-Stay Quality Measure Coding Improvements QAPI Relay Residents Who Self-Report Moderate to Severe Pain Long-Stay Quality Measure Coding Improvements Stacy Gordon, RN, MS, RAC-CT Senior Quality Improvement Facilitator May 2018 1 Today s Call is

More information

Sleep Better. Program Workbook

Sleep Better. Program Workbook Sleep Better Program Workbook Welcome! You are taking a big step in creating forward movement for your life! The Sleep Better program is designed to educate you and show you how to work toward improving

More information

Recognition and Management of Behavioral Disturbances in Dementia

Recognition and Management of Behavioral Disturbances in Dementia Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic

More information

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL DID YOU KNOW THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL. Did you know that it is essential to know the target cluster(s)/symptom(s) one is treating to guide and monitor non-pharmacological approaches and pharmacological

More information

CEPP National Audit Antipsychotics in Dementia

CEPP National Audit Antipsychotics in Dementia CEPP National Audit Antipsychotics in Dementia December 2018 This document has been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG)

More information

Dementia Support Across the Care Continuum

Dementia Support Across the Care Continuum Dementia Support Across the Care Continuum Michelle Niedens, L.S.C.S.W. Director of Education, Programs and Public Policy Alzheimer's Association - Heart of America Chapter July 16, 2015 DEMENTIA SUPPORT

More information

Improving Dementia Care in Nursing Homes Through Best Care Practices

Improving Dementia Care in Nursing Homes Through Best Care Practices Improving Dementia Care in Nursing Homes Through Best Care Practices Morris J. Kaplan, Esq., NHA President, Kaplan Health Management, LLC Operating Partner, Gwynedd Square Nursing Center 5 Star Rated by

More information

PSYCHOTROPIC SOLUTIONS

PSYCHOTROPIC SOLUTIONS PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Hello everyone. Today we will be discussing the

More information

Management of Behavioral Problems in Dementia

Management of Behavioral Problems in Dementia Management of Behavioral Problems in Dementia Ghulam M. Surti, MD Clinical Assistant Professor Department of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Definition of

More information

Improving the quality of care of patients with delirium

Improving the quality of care of patients with delirium Improving the quality of care of patients with delirium Alasdair MacLullich MRCP(UK), PhD Professor of Geriatric Medicine University of Edinburgh Scotland How are we doing now? We are doing badly. Difficult

More information

Northumbria Healthcare NHS Foundation Trust. Your guide to understanding Delirium. Issued by Department of Medicine

Northumbria Healthcare NHS Foundation Trust. Your guide to understanding Delirium. Issued by Department of Medicine Northumbria Healthcare NHS Foundation Trust Your guide to understanding Delirium Issued by Department of Medicine Purpose of this leaflet This leaflet is for patients and carers and aims to give you information

More information

Wicking Dementia Research & Education Centre, University of Tasmania, 2017

Wicking Dementia Research & Education Centre, University of Tasmania, 2017 Wicking Dementia Research & Education Centre, University of Tasmania, 2017 Westbury, J., Gee, P., Ling, T., Bindoff, I., Brown, D., Franks, K., Hoyle, D., Peterson, G. (2017). Reducing the Use of Sedative

More information

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES Coleen Kayden, RPh Medication Information Services Division of Williams Apothecary Conflicts of Interest None to report PANAC

More information

PSYCHOTROPIC SOLUTIONS

PSYCHOTROPIC SOLUTIONS PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF

More information

Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context

Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context Lelly Oboh Consultant Pharmacist, Care of older people and

More information

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document.

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document. Enclosure No: Agenda item No: Author: Contact: xx/xxxxx/xxxx0918 xx CEPP National Audit: Antipsychotics in Dementia All Wales Therapeutics and Toxicology Centre Tel: 02920 71 6900 awttc@wales.nhs.uk 1.0

More information

Introduction to Dementia: Complications

Introduction to Dementia: Complications Introduction to Dementia: Complications Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:

More information

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Define BPSD and review the spectrum of associated symptoms Review pharmacologic and non-pharmacologic treatments for BPSD Evaluate

More information

KINGSTON DEMENTIA RATING SCALE

KINGSTON DEMENTIA RATING SCALE KINGSTON DEMENTIA RATING SCALE -KDRS- I-RatingForm II - Instruction Manual III - Score Interpretation IV - Chart Summary Copyright 2015 R.W. Hopkins, L. Kilik Semoprs Mental Health, Providence Care, Mental

More information

Dementia Training Session for Carers. By Dr Rahul Tomar Consultant Psychiatrist

Dementia Training Session for Carers. By Dr Rahul Tomar Consultant Psychiatrist Dementia Training Session for Carers By Dr Rahul Tomar Consultant Psychiatrist Dementia in the UK: Facts & Figures National Dementia strategy launched in 2009 800,000 people living with dementia (2012)

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information

Non-pharmacological Approaches in Dementia Care. Dr. Anna Fisher

Non-pharmacological Approaches in Dementia Care. Dr. Anna Fisher Non-pharmacological Approaches in Dementia Care Dr. Anna Fisher What is Dementia Dementia is a group of symptoms that may accompany certain diseases or conditions Symptoms many involve changes in personality,

More information

Dementia Care Principles

Dementia Care Principles New CMS Surveyor Guidance: Care & Services for a Resident with Dementia Cat Selman, BS www.thehealthcarecommunicators.com 2015 The Healthcare Communicators, Inc. All rights reserved. Dementia Care Principles

More information

N.C. Nurse Aide I Curriculum MODULE T. Dementia and Alzheimer s Disease. DHSR/HCPR/CARE NAT I Curriculum - July

N.C. Nurse Aide I Curriculum MODULE T. Dementia and Alzheimer s Disease. DHSR/HCPR/CARE NAT I Curriculum - July N.C. Nurse Aide I Curriculum MODULE T Dementia and Alzheimer s Disease DHSR/HCPR/CARE NAT I Curriculum - July 2013 1 Objectives Define the terms dementia, Alzheimer s s disease, and delirium. Describe

More information

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management Issue date: July 2010 Delirium Diagnosis, prevention and management Developed by the National Clinical Guideline Centre for Acute and Chronic Conditions About this booklet This is a quick reference guide

More information

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE Objectives At the conclusion of the session, participants will be

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Psychosocial Outcome Severity Guide Instructor s Guide

Psychosocial Outcome Severity Guide Instructor s Guide Centers for Medicare & Medicaid Services (CMS) Instructor s Guide 2006 Prepared by: American Institutes for Research 1000 Thomas Jefferson St, NW Washington, DC 20007 Slide 1 Psychosocial Outcome Severity

More information

Non-Pharmacological Interventions for Persons With Dementia. John Erpenbach, CNP Michele Snyders, LCSW, ACHP-SW

Non-Pharmacological Interventions for Persons With Dementia. John Erpenbach, CNP Michele Snyders, LCSW, ACHP-SW Non-Pharmacological Interventions for Persons With Dementia John Erpenbach, CNP Michele Snyders, LCSW, ACHP-SW Prevalence3 5.5 million people in the United States are aging with dementia and complex comorbidities

More information

GERIATRIC ADULT MENTAL HEALTH SPECIALTY TEAM TRAINING MODULES

GERIATRIC ADULT MENTAL HEALTH SPECIALTY TEAM TRAINING MODULES GERIATRIC ADULT MENTAL HEALTH SPECIALTY TEAM TRAINING MODULES Title of Presentation Length Description ACCEPTING THE CHALLENGE DVD created by Alzheimer s NC. ALTERNATIVES TO RESTRAINTS 1 hour Overview

More information

Palliative Care for People Living with Dementia: Why Comfort Matters. Learning Objectives. Participants will: The Beatitudes Campus Story

Palliative Care for People Living with Dementia: Why Comfort Matters. Learning Objectives. Participants will: The Beatitudes Campus Story Palliative Care for People Living with Dementia: Why Comfort Matters Tena Alonzo Education & Research Director Learning Objectives Participants will: 1. Describe two expectations for people experiencing

More information

October 28, Geriatrics Update Course. Lesley Wiesenfeld, MD, MHCM, FRCPC. Managing BPSD. Geriatric Psychiatrist, Mount Sinai Hospital

October 28, Geriatrics Update Course. Lesley Wiesenfeld, MD, MHCM, FRCPC. Managing BPSD. Geriatric Psychiatrist, Mount Sinai Hospital October 28, 2016 Geriatrics Update Course Managing BPSD Lesley Wiesenfeld, MD, MHCM, FRCPC Geriatric Psychiatrist, Mount Sinai Hospital Disclosures ~No Pharmaceutical or Industry Support ~ No Health Without

More information

Managing Behavioral Issues

Managing Behavioral Issues 2:45 3:45pm Caring for the Older Patient Handling Behavioral Issues Presenter Disclosure Information The following relationships exist related to this presentation: Samir Sabbag, MD, has no financial relationships

More information

5/17/2017. Conflicts of Interest. Key Takeaways

5/17/2017. Conflicts of Interest. Key Takeaways Antipsychotic Medications: The Balance Between Quality of Care and Quality of Life Coleen M Kayden, RPh Medication Information Services A Division of Williams Apothecary Pennsylvania Restraint Reduction

More information

Dementia Information Kit for HACC Workers

Dementia Information Kit for HACC Workers Dementia Information Kit for HACC Workers This presentation has been compiled as part of the Loddon Mallee region Dementia Management Strategy project in 2002 and revised in 2008 to assist HACC workers

More information

Decreasing Delirium Resolution Times for the Elderly: An Interprofessional Approach

Decreasing Delirium Resolution Times for the Elderly: An Interprofessional Approach Decreasing Delirium Resolution Times for the Elderly: An Interprofessional Approach Featuring: Felice Rogers Evans BSN RN BC Ty Breiter MSN RN CNL Tampa General Hospital NICHE exemplar hospital Three time

More information

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.

More information

Patient and Family Engagement Campaign; Dementia Friendly Hospital Initiative

Patient and Family Engagement Campaign; Dementia Friendly Hospital Initiative Patient and Family Engagement Campaign; Dementia Friendly Hospital Initiative MO-14-09-PREV June 2014 This material was prepared by Primaris, the Medicare Quality Improvement Organization for Missouri,

More information

Workshop 5: Mapping A QAPI Journey around Falls Dr. Anna Fisher / Barb Sisarcick / Claire Enright

Workshop 5: Mapping A QAPI Journey around Falls Dr. Anna Fisher / Barb Sisarcick / Claire Enright Workshop 5: Mapping A QAPI Journey around Falls Dr. Anna Fisher / Barb Sisarcick / Claire Enright 1 Objectives Apply the elements of QAPI and root cause analysis to address falls. Using case scenarios,

More information

We know you will have questions

We know you will have questions Status Change PASRR Objectives After this presentation, the participant will understand: MDS guidance on new PASRR referrals How to determine if a resident has been identified by PASRR to have a mental

More information

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines Program Learning Objectives At the conclusion of the activity, participants should be able to: Have a basic understanding

More information

Telepsychiatry In Rural Nursing Homes

Telepsychiatry In Rural Nursing Homes Telepsychiatry In Rural Nursing Homes Andrew Rosenzweig MD, MPH Chief Medical Officer, Forefront TeleCare Assistant Clinical Professor, Brown University cope of Problem: evere Unmet Need Over 5,000 rural/hpa

More information

Lori Hintz, RN Quality Improvement Advisor Great Plains Quality Innovation Network SD Foundation for Medical Care

Lori Hintz, RN Quality Improvement Advisor Great Plains Quality Innovation Network SD Foundation for Medical Care Lori Hintz, RN Quality Improvement Advisor Great Plains Quality Innovation Network SD Foundation for Medical Care What s Your Number? Understanding the Quality Measure Composite Score and Composite Score

More information

Session outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review

Session outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review Dementia 1 Session outline Introduction to dementia Assessment of dementia Management of dementia Follow-up Review 2 Activity 1: Person s story Present a person s story of what it feels like to live with

More information

Delirium Information for patients and relatives. Delirium is common Delirium is treatable Relatives can stay to help us

Delirium Information for patients and relatives. Delirium is common Delirium is treatable Relatives can stay to help us Delirium Information for patients and relatives Delirium is common Delirium is treatable Relatives can stay to help us What is delirium? Delirium is caused by a disturbance of brain function. It is used

More information

Parkinsonian Disorders with Dementia

Parkinsonian Disorders with Dementia Parkinsonian Disorders with Dementia George Tadros Consultant in Old Age Liaison Psychiatry, RAID, Heartlands Hospital Professor of Dementia and Liaison Psychiatry, Aston Medical School Aston University

More information

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Professor Clive Ballard Dr Byron Creese University of Exeter, UK Guardian guide for 2018: Top

More information

Working Together to Enhance Understanding of Responsive Behaviours in Long-Term Care

Working Together to Enhance Understanding of Responsive Behaviours in Long-Term Care Working Together to Enhance Understanding of Responsive Behaviours in Long-Term Care Sherry Dupuis, PhD Director, MAREP Long-Term Care Association of Manitoba Annual Conference May 29, 2007 Winnipeg, Manitoba

More information

Clear Webinar Series: Person Centered Approach & Recreation Therapy. May 24, 2018

Clear Webinar Series: Person Centered Approach & Recreation Therapy. May 24, 2018 Clear Webinar Series: Person Centered Approach & Recreation Therapy May 24, 2018 Please note: This webinar is being recorded Personal information in this initiative is collected under s.26(c) and 26(d)(ii)

More information

Managing Challenging Behaviors

Managing Challenging Behaviors Managing Challenging Behaviors Barbara J. Kocsis, MD Psychiatry Resident, HDSA Center of Excellence UC Davis School of Medicine In partnership with Drs. Lorin Scher, MD and Vicki Wheelock, MD 1 Our Goal

More information

Delirium Prevention: The State-of-the-Art & Implications to Improve Care in our State

Delirium Prevention: The State-of-the-Art & Implications to Improve Care in our State Delirium Prevention: The State-of-the-Art & Implications to Improve Care in our State Jonny Macias, MD & Michael Malone, MD Aurora Health Care/ University of Wisconsin School of Medicine & Public Health

More information

Palliative Care Consult Service

Palliative Care Consult Service Creating Program Elements to Improve the Care of the Dementia Patient in Palliative & Hospice Settings Carla Jolley MN, ARNP, ANP-BC, AOCN, ACHPN Palliative Care APN/Program Coordinator WhidbeyHealth Palliative

More information

Multi-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School

Multi-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School Multi-morbidity in Dementia: A 21st Century Challenge Sube Banerjee Professor of Dementia Brighton and Sussex Medical School Most people of any age with any long term condition have multiple conditions

More information

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs Across the Spectrum of Dementia Keys to Understanding Behaviours & Anticipating Needs Outline Review current predictions for dementia prevalence, & the implications for future needs Discuss retrogenesis

More information

Confused Hospitalised Older Persons Program CHOPS. 26 th March 2015 HNE Falls Forum

Confused Hospitalised Older Persons Program CHOPS. 26 th March 2015 HNE Falls Forum Confused Hospitalised Older Persons Program CHOPS 26 th March 2015 HNE Falls Forum Dementia Not a normal part of ageing 1/5 people over 80 have moderate to severe dementia ½ over 90 Dementia in Australia

More information

Addressing Difficult Behaviors in Dementia

Addressing Difficult Behaviors in Dementia Addressing Difficult Behaviors in Dementia GEORGE SCHOEPHOERSTER, MD GERIATRICIAN GENEVIVE/CENTRACARE CLINIC Objectives By the end of the session, you will be able to: 1) Explain the role of pain management

More information

Home Health (2-Hour) Online Dementia Care Training Program

Home Health (2-Hour) Online Dementia Care Training Program Your Name: Date: Home Health (2-Hour) Online Dementia Care Training Program Module 1 Worksheet: INTRODUCTION TO DEMENTIA 1. You just met Mrs. Clara Jones. Think about Mr. Sanchez, a person with dementia

More information

Deidre Pye MClinPsych Senior Behaviour Consultant Dementia Behaviour Management Advisory Service (Qld)

Deidre Pye MClinPsych Senior Behaviour Consultant Dementia Behaviour Management Advisory Service (Qld) Deidre Pye MClinPsych Senior Behaviour Consultant Dementia Behaviour Management Advisory Service (Qld) Not about reinventing the wheel Processes May feel uncomfortable or challenged by different ideas

More information

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline I. Geriatric Psychiatry Patient Care and Procedural Skills Core Competencies A. Geriatric psychiatrists shall

More information

Dementia & Delirium: Contents. Behaviours, Symptoms & Integrated Person-Centred Care. You & Your Care Dementia Pg.

Dementia & Delirium: Contents. Behaviours, Symptoms & Integrated Person-Centred Care. You & Your Care  Dementia Pg. Dementia & Delirium: Contents Dementia Pg. 2 Common Types of Dementia Pg. 2 Behavioural & Psychological Symptoms of Dementia (BPSD) Pg. 2 Symptoms of BPSD Pg. 3 Causes of BPSD Pg. 3 Managing BPSD Pg. 3

More information

Neuropsychiatric Inventory Nursing Home Version (NPI-NH)

Neuropsychiatric Inventory Nursing Home Version (NPI-NH) This is a Sample version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) The full version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) comes without sample watermark..

More information

Beyond the Bath: Leading Dementia Care in Long Term Care

Beyond the Bath: Leading Dementia Care in Long Term Care Beyond the Bath: Leading Dementia Care in Long Term Care Wilma Greene MN, CNS Paula Walters, MEd, CNS 1 Define and explain Behavioral and Psychological Symptoms of Dementia (BPSD) Present prevalence of

More information

Dementia in Long Term Care: How Dementia Affects Care Planning

Dementia in Long Term Care: How Dementia Affects Care Planning Volume XXII Dementia in Long Term Care: How Dementia Affects Care Planning A Video Guide for Employing Breakthroughs in Clinical Care Facilitator Guide [1] DEMENTIA IN LONG TERM CARE: HOW DEMENTIA AFFECTS

More information

Supporting people with dementia to live well in London care homes

Supporting people with dementia to live well in London care homes Supporting people with dementia to live well in London care homes London Dementia Clinical Network Date Dr Daniel Harwood; Clinical Director and Consultant Psychiatrist SLAM (Lewisham Care Home Intervention

More information

nicheprogram.org 16th Annual NICHE Conference Forging New Paths and Partnerships 1

nicheprogram.org 16th Annual NICHE Conference Forging New Paths and Partnerships 1 Improving Patient Outcomes in Geriatric Post-Operative Orthopedic Patients: Translating Research into Practice Tripping into The CAM Presented by: Diana LaBumbard, RN, MSN, ACNP/GNP-BC, CWOCN Denise Williams,

More information

Assessment and management of behavioral and psychological symptoms of dementia

Assessment and management of behavioral and psychological symptoms of dementia Assessment and management of behavioral and psychological symptoms of dementia Helen C Kales, 1 2 3 Laura N Gitlin, 4 5 6 Constantine G Lyketsos 7 1 Section of Geriatric Psychiatry, Department of Psychiatry,

More information

Behavioral and Psychological Symptoms of dementia (BPSD)

Behavioral and Psychological Symptoms of dementia (BPSD) Behavioral and Psychological Symptoms of dementia (BPSD) Chris Collins - Old Age Psychiatrist, Christchurch chris.collins@cdhb.health.nz Approaching BPSD: the right mindset Assessment Non-drug management

More information

Talking to Patients and Their Families

Talking to Patients and Their Families Talking to Patients and Their Families About Clozapine The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health

More information

How Aging and Dementia Effect Resident Behaviors

How Aging and Dementia Effect Resident Behaviors How Aging and Dementia Effect Resident Behaviors November 3, 2011 1:00 2:00 PM EST Webinar Presented by: Alfred W. Norwood, BS, MBA Education Arm of the Carmelite Sisters for the Aged and Infirm Webinar

More information

BEHAVIORAL PROBLEMS IN DEMENTIA

BEHAVIORAL PROBLEMS IN DEMENTIA BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer

More information

We Will Discuss. Dementia and Alzheimer s Disease Basics. Dementia. Developmental Disabilities and Dementia: A Behavior Management Guide

We Will Discuss. Dementia and Alzheimer s Disease Basics. Dementia. Developmental Disabilities and Dementia: A Behavior Management Guide 10/18/2013 1 Dayna Thompson M.S., LMHC Alzheimer s Educator Developmental Disabilities and Dementia: A Behavior Management Guide Alzheimer s Resource Service IU Health Bloomington-Community Health 812-353-9299

More information

Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved

Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved Defining Dementia Dementia is a group of symptoms affecting intellectual and social abilities severely

More information

Summary of funded Dementia Research Projects

Summary of funded Dementia Research Projects Summary of funded Dementia Research Projects Health Services and Delivery Research (HS&DR) Programme: HS&DR 11/2000/05 The detection and management of pain in patients with dementia in acute care settings:

More information

Delirium. Delirium is characterized by an acute onset (hours or days) and fluctuating course of deterioration in mental functioning.

Delirium. Delirium is characterized by an acute onset (hours or days) and fluctuating course of deterioration in mental functioning. Delirium Delirium is characterized by an acute onset (hours or days) and fluctuating course of deterioration in mental functioning. DELIRIUM IS A MEDICAL EMERGENCY! Delirium: Hallmark Features Inattention-

More information